(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IQTIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IQTIN

ST13

US500000097160162

Class

5

Filing

97160162

Registration

8253890

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

48

Latest update

05/12/2026

Trademark type

Word

Nice classes

5

Filing date

12/07/2021

Registration date

05/12/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/12/2026

Last transaction

05/12/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/22/2022

First use in commerce

12/22/2022

Drawing code

4

Owner type

03

Owner location

Wollerau, CH

Examiner

LIU, PHILIP HUAI-EN

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

System Biologie AG

Representatives

Erik M. Pelton ERIK M. PELTON & ASSOCIATES, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Dietary supplements; Anti-inflammatories; Anti-inflammatory gels; Anti-inflammatory preparations; Veterinary preparationsantioxidants; Central nervous system stimulants; Extracts of medicinal herbs; Extracts of medicinal plants; Herbal compoundsherbal supplements; Herbal supplements; Immunostimulants; Immunomodulators; Medicated food supplements; Medicinal herbs; Medicinal drinks; Medicines for humansneurodegenerative and Inflammageing medicines; Medicine for neurodegenerativeepigeneticinflammation disorders; Medicinal preparations and substances for neurodegenerative and epigenetic disorders; Nutraceutical preparations for therapeutic or medical purposes in the form of a dietary supplement; Nutraceuticals for therapeutic purposes for use as a dietary supplement; Pharmaceutical preparations for preparations for the prevention of diseases of the nervous system; Pharmaceutical preparations for the prevention of diseases of the metabolic system; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of diseases of the endocrine system; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of Alzheimer'sParkinson'sDementia and inflammatory diseases; Phytotherapy preparations for medical purposes; Plant and herb extracts for medicinal use; Plant extracts for pharmaceutical purposes; Dietary supplement drink mixes; Dietary supplemental drinks; Dietary supplements for humans; Dietetic beverages adapted for medical purposes; Dietetic food preparations adapted for medical usenamely dietetic beverages; Dietetic foods adapted for medical purposes; Dietetic substancesnamely dietetic beverages adapted for medical use; Food supplements; Food supplements in liquid form; Liquid herbal supplements; Liquid vitamin supplements; Mineral nutritional supplements; Mineral food supplements; Nutritional supplements; Nutraceuticals for use as a dietary supplement; Nutraceutical preparations for humansnutraceuticals for use as a dietary supplements for promoting overall health

Publications

History of USPTO decisions and trademark events.

48 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/12/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

05/12/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/22/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/22/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/22/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/22/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/01/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/17/2024

GNRT

NON-FINAL ACTION E-MAILED

07/17/2024

CNRT

SU - NON-FINAL ACTION - WRITTEN

07/17/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/21/2024

IUAF

USE AMENDMENT FILED

06/20/2024

EISU

TEAS STATEMENT OF USE RECEIVED

06/20/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/10/2024

EX1G

SOU EXTENSION 1 GRANTED

01/09/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/09/2024

EXT1

SOU EXTENSION 1 FILED

12/18/2023

EEXT

SOU TEAS EXTENSION RECEIVED

12/18/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/20/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/25/2023

PUBO

PUBLISHED FOR OPPOSITION

04/25/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/05/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/22/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

03/22/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/22/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

03/22/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/22/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/20/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/20/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

03/20/2023

GNS1

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

03/16/2023

GNCF

CONTINUATION OF FINAL REFUSAL E-MAILED

03/16/2023

CNCF

ACTION CONTINUING A FINAL - COMPLETED

03/16/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/15/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/15/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

03/15/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

12/29/2022

GNFR

FINAL REFUSAL E-MAILED

12/29/2022

CNFR

FINAL REFUSAL WRITTEN

12/29/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/28/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/28/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/28/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/16/2022

GNRT

NON-FINAL ACTION E-MAILED

09/16/2022

CNRT

NON-FINAL ACTION WRITTEN

09/16/2022

DOCK

ASSIGNED TO EXAMINER

09/15/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/13/2021

NWAP

NEW APPLICATION ENTERED

12/10/2021

Continuous trademark protection

Get notified about every new filing that threatens IQTIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.